FDA pharmacologic class
Calcitonin Gene-related Peptide Receptor Antagonist
4 medicines are in FDA's class of calcitonin gene-related peptide receptor antagonists: ubrogepant (Ubrelvy), atogepant (Qulipta), rimegepant (Nurtec) and zavegepant (Zavzpret). 0 of the 4 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is qulipta 10 mg tablet at $38.36 per tablet (NADAC).
Which medicines are calcitonin gene-related peptide receptor antagonist?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Ubrogepant | Ubrelvy | none listed | $109.11 per tablet 100 mg tablet | No | No current entry | 0 |
| Atogepant | Qulipta | none listed | $38.36 per tablet 10 mg tablet | No | No current entry | 0 |
| Rimegepant | Nurtec | none listed | $128.67 per tablet 75 mg tablet | No | No current entry | 1 |
| Zavegepant | Zavzpret | none listed | $189.80 per unit 10 mg nasal spray | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price